Evidence map›Paper›PMID 37419334›Full record

ArticleThe Journal of allergy and clinical immunology2023

Comprehensive phenotypic analysis of diverse FOXN1 variants.

Angela Moses, Pratibha Bhalla, Austin Thompson, Laijun Lai, Fatma S Coskun, Christine M Seroogy, Maria Teresa de la Morena, Christian A Wysocki, Nicolai S C van Oers

Open access · hybridAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Runx3 instructs AireJournal of autoimmunity · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Informed clinical decisions by outfoxing human FOXN1 variants.The Journal of allergy and clinical immunology · 2025
    Review
  7. Article
  8. Immunosenescence: signaling pathways, diseases and therapeutic targets.Signal transduction and targeted therapy · 2025
    Review
  9. Thymic inborn errors of immunity.The Journal of allergy and clinical immunology · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Angela MosesDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, Tex.
Pratibha BhallaDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, Tex.
Austin ThompsonDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, Tex.
Laijun LaiDepartment of Allied Health Sciences, University of Connecticut, Storrs, Conn.
Fatma S CoskunDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, Tex.
Christine M Seroogythe Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
Maria Teresa de la Morenathe Department of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, Wash.
Christian A WysockiDepartments of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Tex; Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Tex.
Nicolai S C van OersDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, Tex; Departments of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Tex; Microbiology, University of Texas Southwestern Medical Center, Dallas, Tex. Electronic address: Nicolai.vanoers@utsouthwestern.edu.
The University of Texas Southwestern Medical Center · USSeattle Children's Hospital · USSouthwestern Medical Center · USUniversity of Connecticut · USUniversity of Wisconsin–Madison · US

Funding

Long noncoding RNAs and their contribution to 22q11.2 deletion syndromeR01AI114523 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI VAN OERS, NICOLAI STANISLAS CYRILLE · 2015 to 2024
$4.1M
T CELL RECEPTOR SIGNALING BY PHOSPHORYLATED FORMS OF TCRR01AI042953 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI VAN OERS, NICOLAI STANISLAS CYRILLE · 1999 to 2008
$2.4M
The Functions of Novel FOXN1 Compound Heterozygous Mutations in PIDs PatientsR21AI144140 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI VAN OERS, NICOLAI STANISLAS CYRILLE · 2019 to 2020
$446k
FOXN1 variant regulation of T cell productionR21AI188004 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI VAN OERS, NICOLAI STANISLAS CYRILLE · 2025 to 2025
$436k
NIAID NIH HHS R01 AI042953NIAID NIH HHS R01 AI114523NIAID NIH HHS R21 AI144140NIAID NIH HHS R21 AI188004
6 · The paper itself

Abstract

backgroundThymus hypoplasia due to stromal cell problems has been linked to mutations in several transcription factors, including Forkhead box N1 (FOXN1). FOXN1 supports T-cell development by regulating the formation and expansion of thymic epithelial cells (TECs). While autosomal recessive FOXN1 mutations result in a nude and severe combined immunodeficiency phenotype, the impact of single-allelic or compound heterozygous FOXN1 mutations is less well-defined.

objectiveWith more than 400 FOXN1 mutations reported, their impact on protein function and thymopoiesis remains unclear for most variants. We developed a systematic approach to delineate the functional impact of diverse FOXN1 variants.

methodsSelected FOXN1 variants were tested with transcriptional reporter assays and imaging studies. Thymopoiesis was assessed in mouse lines genocopying several human FOXN1 variants. Reaggregate thymus organ cultures were used to compare the thymopoietic potential of the FOXN1 variants.

resultsFOXN1 variants were categorized into benign, loss- or gain-of-function, and/or dominant-negatives. Dominant negative activities mapped to frameshift variants impacting the transactivation domain. A nuclear localization signal was mapped within the DNA binding domain. Thymopoiesis analyses with mouse models and reaggregate thymus organ cultures revealed distinct consequences of particular Foxn1 variants on T-cell development.

conclusionsThe potential effect of a FOXN1 variant on T-cell output from the thymus may relate to its effects on transcriptional activity, nuclear localization, and/or dominant negative functions. A combination of functional assays and thymopoiesis comparisons enabled a categorization of diverse FOXN1 variants and their potential impact on T-cell output from the thymus.

Indexed as

Thymus GlandT-LymphocytesAnimalsCell DifferentiationEpithelial CellsForkhead Transcription FactorsHumansMicePhenotypeForkhead Transcription FactorsWhn proteinFOXN1reaggregate thymus organ culturesT-cell immunodeficiencyThymopoiesisthymus epithelial cellsTRECs

Identifiers

PMID37419334
PMCPMC11071152
OpenAlexW4383215359

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.